Literature DB >> 493559

Prostaglandin and thromboxane production by human and guinea-pig macrophages and leucocytes.

J Morley, M A Bray, R W Jones, D H Nugteren, D A van Dorp.   

Abstract

The ability of partially purified human and guinea-pig haematogenous cell populations, when cultured in vitro, to metabolise arachidonic acid (AA) has been studied. Supernatants from 24 hour cell culture have been subjected to analysis for products of AA metabolism by gas chromatography with electron-capture detection. The cell types studied were human peripheral blood monocytes (both glass adherent and non-adherent), neutrophils, eosinophils and leukemia leucocytes; thoracic duct lymphocytes and lung alveolar macrophages. From the guinea-pig, induced and non-induced macrophage or neutrophil enriched peritoneal exudate populations, lymph node cells, peritoneal eosinophils and peripheral blood platelets were examined. Supernatants were assayed for the presence of PGE2, PGD2, PGF2 alpha, TXB2 and 6-keto-PGF1 alpha. In all types studied PGE2 and TXB2 were the major products formed. The identification of PGE2 and TXB2 was confirmed by GC/MS with multiple ion monitoring. The results have been compared with other reports and their possible significance discussed in relation to the proposed role of prostaglandins as mediators and modulators in immunopathology.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 493559     DOI: 10.1016/s0090-6980(79)80044-1

Source DB:  PubMed          Journal:  Prostaglandins        ISSN: 0090-6980


  25 in total

Review 1.  The role of eosinophils in asthma.

Authors:  C Kroegel
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  Platelet activating factor and asthma.

Authors:  J Morley
Journal:  Agents Actions       Date:  1986-10

3.  Proteolytic enzymes and arachidonic acid metabolites produced by MRC-5 cells on various microcarrier substrates.

Authors:  J Varani; J D Hasday; R G Sitrin; P G Brubaker; W A Hillegas
Journal:  In Vitro Cell Dev Biol       Date:  1986-10

4.  Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators.

Authors:  P B Bitterman; M D Wewers; S I Rennard; S Adelberg; R G Crystal
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

Review 5.  The role of prostaglandins in altered leukocyte function in multiple sclerosis.

Authors:  P Dore-Duffy; S Y Ho; M Longo
Journal:  Springer Semin Immunopathol       Date:  1985

6.  Release of prostaglandin E and thromboxane from macrophages by stimulation with factor H.

Authors:  H P Hartung; U Hadding; D Bitter-Suermann; D Gemsa
Journal:  Clin Exp Immunol       Date:  1984-05       Impact factor: 4.330

7.  Enhancement of lymphocyte activation by BW755C in vitro.

Authors:  A T Ali; J Morley
Journal:  Agents Actions       Date:  1982-12

8.  Effects of non-steroidal anti-inflammatory drugs on lymphocyte activation.

Authors:  A T Ali; J M Hanson; J Morley
Journal:  Agents Actions       Date:  1984-02

9.  Human alveolar macrophage growth factor for fibroblasts. Regulation and partial characterization.

Authors:  P B Bitterman; S I Rennard; G W Hunninghake; R G Crystal
Journal:  J Clin Invest       Date:  1982-10       Impact factor: 14.808

10.  Human recombinant interleukin-1 beta induces thromboxane A2 release in polymorphonuclear leukocytes, macrophages and platelets: effect of IL-1 receptor antagonist.

Authors:  M Reale; R C Barbacane; S Frydas; G Anogianakis; A Trakatellis; D Dimitriadou; D Vacalis; F C Placido; P De Fazio; E Porreca; C Di Febbo; P Conti
Journal:  Mol Cell Biochem       Date:  1996-06-21       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.